Cargando…

Risk stratification and prognosis prediction based on inflammation‐related gene signature in lung squamous carcinoma

BACKGROUND: Inflammation is known to have an intricate relationship with tumorigenesis and tumor progression while it is also closely related to tumor immune microenvironment. Whereas the role of inflammation‐related genes (IRGs) in lung squamous carcinoma (LUSC) is barely understood. Herein, we rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Wenyu, Chen, Si, Duan, Fangfang, Wang, Junye, Zhao, Zerui, Lin, Yaobin, Rao, Bingyu, Wang, Yizhi, Zheng, Lie, Long, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972108/ https://www.ncbi.nlm.nih.gov/pubmed/36056909 http://dx.doi.org/10.1002/cam4.5190

Ejemplares similares

A novel diagnostic model for predicting immune microenvironment subclass based on costimulatory molecules in lung squamous carcinoma
por: Duan, Fangfang, et al.
Publicado: (2022)

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma
por: Zhai, Wen-Yu, et al.
Publicado: (2022)

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer
por: Yuan, Jing, et al.
Publicado: (2021)

A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Zhai, Wen-Yu, et al.
Publicado: (2022)

The impact of an N1 lymph node examination in patients with early-stage non-small cell lung cancer: a retrospective cohort study
por: Zhai, Wenyu, et al.
Publicado: (2021)

Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer
por: Jiang, Long, et al.
Publicado: (2015)

Comprehensive (18)F-FDG PET-based radiomics in elevating the pathological response to neoadjuvant immunochemotherapy for resectable stage III non-small-cell lung cancer: A pilot study
por: Cui, Yingpu, et al.
Publicado: (2022)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

Modified inflammation-based score as an independent malignant predictor in patients with pulmonary focal ground-glass opacity: a propensity score matching analysis
por: Jiang, Long, et al.
Publicado: (2016)

A TRP Family Based Signature for Prognosis Prediction in Head and Neck Squamous Cell Carcinoma
por: Pan, Fangfang, et al.
Publicado: (2022)

Identification of a Novel Tumor Inflammation Signature for Risk Stratification, Prognosis Prediction, and Immune Status in Colorectal Cancer
por: Li, Yayun, et al.
Publicado: (2022)

Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA–IIA non-small cell lung cancer, a retrospective cohort study
por: Zhai, Wenyu, et al.
Publicado: (2020)

Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer
por: Wang, Hao, et al.
Publicado: (2019)

Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas
por: Menor, Mark, et al.
Publicado: (2019)

Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer
por: Lin, Yaobin, et al.
Publicado: (2022)

Novel immune‐related signature for risk stratification and prognosis in prostatic adenocarcinoma
por: Zhao, Hai‐Bo, et al.
Publicado: (2021)

Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma
por: Lu, Yilong, et al.
Publicado: (2022)

Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer
por: Fei, Hongjun, et al.
Publicado: (2023)

Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma
por: Long, Shengrong, et al.
Publicado: (2023)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
por: Li, Quanxiao, et al.
Publicado: (2021)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration
por: Chi, Hao, et al.
Publicado: (2022)

A novel immune-related radioresistant lncRNAs signature based model for risk stratification and prognosis prediction in esophageal squamous cell carcinoma
por: Zheng, Jianqing, et al.
Publicado: (2022)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

Development of novel gene signatures for the risk stratification of prognosis and diagnostic prediction of osteosarcoma patients using bioinformatics analysis
por: Li, Guoquan, et al.
Publicado: (2022)

A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients
por: Yu, Yanling, et al.
Publicado: (2022)

Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature
por: Liu, Hua-Ping, et al.
Publicado: (2023)

A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma
por: Sun, Jianping, et al.
Publicado: (2023)

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Xu, Qian, et al.
Publicado: (2021)

Bioinformatics Analysis of Inflammation Gene Signature in Indicating Cholangiocarcinoma Prognosis
por: Wang, Yanting, et al.
Publicado: (2022)

Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2
por: Lee, Sumin, et al.
Publicado: (2017)

Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair‐based signature
por: Lu, Xiaofan, et al.
Publicado: (2021)

A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer
por: Ren, Qianhe, et al.
Publicado: (2023)

Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
por: Lin, Dagui, et al.
Publicado: (2021)

Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature
por: Luo, Yongzhou, et al.
Publicado: (2022)

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
por: Lin, Zhu, et al.
Publicado: (2023)

Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma
por: He, Jimin, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition Gene Signature Is Associated with Neoadjuvant Chemoradiotherapy Resistance and Prognosis of Esophageal Squamous Cell Carcinoma
por: Song, Kewei, et al.
Publicado: (2022)

Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma
por: Fu, Denggang, et al.
Publicado: (2020)

Urachal carcinoma: Impact of recurrence pattern and lymphadenectomy on long‐term outcomes
por: Duan, Fangfang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_701i1us2q74a135pqnipg518at